RxDoctor Payments Data

Carolyn Kellaway, PA

Medical · Pinehurst, NCNPI 1457647604

Payments from drug & device makers

$1,379in general payments, 2019–2025

Across 63 payments — averaging $21.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$361
  • Astellas Pharma US Inc$327
  • AbbVie$222
  • Procept Biorobotics Corporation$99
  • Teleflex LLC$76
  • Laborie Medical Technologies Corp.$75
  • plus $221 from 9 others

What the payments were for

  • Food & beverage$1,19487%
  • Education$18513%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,379 in reported general payments places this provider in the 70th percentile of 878 medical providers in North Carolina.

See all medical providers in North Carolina

Medicare billing

Part B allowed, 2024
$226,496
Medicare patients
958
Services billed
6,396

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron379$223,302
GemtesaVibegron162$96,384
Fosfomycin Tromethamine82$22,154
Tamsulosin Hcl1,241$21,744
Trimethoprim303$17,434
Fesoterodine Fumarate ErFesoterodine Fumarate159$15,216
Imipramine Pamoate17$9,077
PremarinEstrogens, Conjugated19$8,221
TradjentaLinagliptin16$8,176
Finasteride630$8,169
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,919
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst215$7,520
Mirabegron ErMirabegron13$6,689
LinzessLinaclotide12$6,366
Potassium Citrate ErPotassium Citrate46$4,911

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$327$223,302379 claims
Sumitomo Pharma America, Inc.Gemtesa$34$96,384162 claims
AbbVieLinzess$222$6,36612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 878 medical providers in North Carolina.

Other medical in Pinehurst

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →